Literature DB >> 1501290

Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence.

F Lori1, L Hall, P Lusso, M Popovic, P Markham, G Franchini, M S Reitz.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) displays both interstrain and intrastrain genetic variability. Virus populations with extensive microheterogeneity have been defined as swarms or quasispecies. Many of the genomes within HIV-1 swarms appear to be defective in one or more genes required for viral replication. It is unclear to what extent defective viruses play a role in the process of HIV-1 infection or in the pathogenesis of AIDS. We have isolated two biologically active HIV-1 clones: LW 12.3, which contains defects in the vif and vpr genes, and MN ST.1, which has a defect in the vpu gene. LW 12.3 is unable to replicate in peripheral blood mononuclear cells (PBMC). The growth of MN-ST.1 in SupT1 cells is marked by a 3-week lag in extracellular virus production and by the presence of unusually abundant viral buds. We demonstrate here that coinfection of PBMC with these two partially defective HIV-1 clones extends the cellular host range of LW 12.3, significantly increases the replication rate of both viral genomes, and eliminates the delay in production observed with the vpu-defective MN ST.1. When the lesions in vpr and vif of LW 12.3 are repaired, the resultant virus grows normally in PBMC. This is also the case when only vif is repaired, indicating that complementation of LW 12.3 in PBMC by MN ST.1 is mediated by vif in trans. The reciprocal complementation results in a dramatic increase of HIV-1 virulence. This two-component model represents a simplified version of the in vivo situation and illustrates one way in which interaction of defective viruses could increase the spread of infection and progression of disease.

Entities:  

Mesh:

Year:  1992        PMID: 1501290      PMCID: PMC289114     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

2.  Complete nucleotide sequences of functional clones of the AIDS virus.

Authors:  L Ratner; A Fisher; L L Jagodzinski; H Mitsuya; R S Liou; R C Gallo; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

3.  Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

Authors:  J Sodroski; W C Goh; C Rosen; A Tartar; D Portetelle; A Burny; W Haseltine
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

4.  Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.

Authors:  R L Willey; R A Rutledge; S Dias; T Folks; T Theodore; C E Buckler; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

6.  Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

Authors:  M S Reitz; C Wilson; C Naugle; R C Gallo; M Robert-Guroff
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

7.  Biologically diverse molecular variants within a single HIV-1 isolate.

Authors:  A G Fisher; B Ensoli; D Looney; A Rose; R C Gallo; M S Saag; G M Shaw; B H Hahn; F Wong-Staal
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

8.  Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.

Authors:  K Sakai; S Dewhurst; X Y Ma; D J Volsky
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats.

Authors:  J Overbaugh; P R Donahue; S L Quackenbush; E A Hoover; J I Mullins
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

10.  Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

Authors:  F Wong-Staal; G M Shaw; B H Hahn; S Z Salahuddin; M Popovic; P Markham; R Redfield; R C Gallo
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

View more
  16 in total

1.  Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Authors:  Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Hiroshi Mohri; Rudolf Bohm; Mohammed Saifuddin; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-01-29       Impact factor: 3.616

2.  Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.

Authors:  S H Pincus; K G Messer; P L Nara; W A Blattner; G Colclough; M Reitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells.

Authors:  J Lisziewicz; D I Gabrilovich; G Varga; J Xu; P D Greenberg; S K Arya; M Bosch; J P Behr; F Lori
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDS.

Authors:  D De Forni; M R Stevens; F Lori
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Authors:  Brian E McGillick; Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

6.  Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus.

Authors:  K M Duus; E D Miller; J A Smith; G I Kovalev; L Su
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.

Authors:  E D Miller; K M Duus; M Townsend; Y Yi; R Collman; M Reitz; L Su
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Characterization of human immunodeficiency virus type 1 Vif particle incorporation.

Authors:  D Camaur; D Trono
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection.

Authors:  M A Ansari-Lari; R A Gibbs
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.

Authors:  S C Kayman; Z Wu; K Revesz; H Chen; R Kopelman; A Pinter
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.